Results 241 to 250 of about 113,763 (312)

Fixed‐Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

American Journal of Hematology, Volume 101, Issue 5, Page 986-997, May 2026.
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett, Laurie H. Sehn, Sarit Assouline, Pratyush Giri, John Kuruvilla, Stephen J. Schuster, Sung‐Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma C. Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Penuel, Vanda Teodoro, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, L. Elizabeth Budde   +20 more
wiley   +1 more source

Health-Related Quality of Life of Spinal Cord Injury Patients Visiting the Outpatient Clinic of a Tertiary Care Rehabilitation Center in Saudi Arabia: Results from a Cross-Sectional Study. [PDF]

Healthcare (Basel)
Alsaleh AJ, Tharkar S, Almutairi KM.
europepmc   +1 more source

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)

International Forum of Allergy &Rhinology, Volume 16, Issue 5, Page 484-494, May 2026.
ABSTRACT Background Loss of smell is a principal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), affecting health‐related quality of life and posing a safety hazard. Methods WAYPOINT (NCT04851964), a phase 3, multicenter trial in adults with uncontrolled CRSwNP, randomized patients 1:1 to receive tezepelumab 210 mg or placebo ...
Joaquim Mullol, Joseph K. Han, Tanya M. Laidlaw, Claire Hopkins, Anju T. Peters, Oliver Pfaar, Martin Desrosiers, Stella E. Lee, Andrew P. Lane, Claudia Chen, Yun Chon, Sandhia S. Ponnarambil, Andrew Foster, Andrew W. Lindsley, Christopher S. Ambrose   +14 more
wiley   +1 more source

Mediating effect of cardiorespiratory fitness on the relationship between inspiratory muscle strength and quality of life in people on hemodialysis. [PDF]

J Bras Nefrol
Pereira JGC, Martins ICM, Macedo CA, Santos JNV, Madeira EAA, Rodrigues VGB, Prates MCSM, Alves FL, Maciel EHB, Lima VP, Costa HS, Mendonça VA, Figueiredo PHS.   +12 more
europepmc   +1 more source

Outcomes of fusions from the cervical spine to the pelvis [PDF]

, 2019
et al.,, Nemani, Venu M
core   +1 more source

Cross‐Cultural Adaptation, Reliability and Validation of the Mini‐OAKHQoL for Knee/Hip Osteoarthritis in a Syrian Arabic‐Speaking Population: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Osteoarthritis (OA) is a degenerative joint disease characterized. The Mini‐Osteoarthritis Knee and Hip Quality of Life (Mini‐OAKHQoL) scale is used to evaluate the impact of knee/hip osteoarthritis (KOA/HOA) on patients' quality of life (QoL).
Ruba Altahla, Jamal Alshorman
wiley   +1 more source

Beyond the Scale: Setting Goals for Outcomes Beyond Weight in Evidence-based Obesity Treatment. [PDF]

Curr Obes Rep
Schumacher LM, Hayes JF, Olson KL, Flanagan SP, Wohler D, Darling KE.   +5 more
europepmc   +1 more source

Health's influence on alcohol use-a longitudinal study of working adults in Sweden. [PDF]

Eur J Public Health
Jonsson E, Elling DL, Landberg J, Helgesson M, Lundin A, Thern E.   +5 more
europepmc   +1 more source

Quality of life in oncology drug approvals: evidence from Swiss decisions in relation to global regulatory trends. [PDF]

Qual Life Res
Horst A, Löffler-Perez N, Rohr UP, Wac K.   +3 more
europepmc   +1 more source

Associations of Long-Term PM2.5 Exposure and Physical Activity Levels with Metabolic Syndrome and Health-Related Quality of Life: A Cross-Sectional Study in Chiang Mai, Thailand. [PDF]

J Clin Med
Nantakool S, Chuatrakoon B, Phirom K, Sittichoke C, Konghakote S.   +4 more
europepmc   +1 more source